Vai al contenuto principale

PI3K signaling in cardiovascular and pulmonary disease

Prof.ssa Alessandra Ghigo (Principal Investigator)

 

Group_photo.jpg

Activities

The research activity is focused on two main topics:

Study of the molecular mechanisms underlying the cardiotoxicity of anti-cancer treatments, such as radiotherapy and chemotherapy

Identification of pharmacological targets for the prevention and the treatment of anti-cancer therapy-related cardiotoxicity, with a major focus on PI3K

Identification of new biomarkers of anti-cancer therapy-related cardiotoxicity

Study of the molecular mechanisms underlying obstructive (Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Bronchiectasis) and restrictive (Idiopathic Pulmonary Fibrosis) airway disease

Validation of new therapeutic targets for the treatment of obstructive and restrictive airway diseases, with a major focus on PI3K

Development of new drugs targeting PI3K for the treatment of obstructive and restrictive airway diseases 

Group

 Prof.ssa A. Ghigo

 

 

 

Ultimo aggiornamento: 27/07/2023 11:43
Non cliccare qui!